Although, pro-IL-33 is proteolytically activated into a bioactive form by caspase-1, 3, 7, it remains unknown whether caspase-mediated processing is operating in IL-33 production by pDCs in AIP and IgG4-RD (53). The gene discussed is IL33; the disease is immunoglobulin G4-related sclerosing disease.